ORUDIS Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Orudis, and what generic alternatives are available?

Orudis is a drug marketed by Wyeth Ayerst and Wyeth Cons and is included in two NDAs.

The generic ingredient in ORUDIS is ketoprofen. There are twenty-seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the ketoprofen profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Orudis

A generic version of ORUDIS was approved as ketoprofen by TEVA on December 22^nd, 1992.

Try a Trial

Summary for ORUDIS

US Patents:	0
Applicants:	2
NDAs:	2
Raw Ingredient (Bulk) Api Vendors:	164
Clinical Trials:	2
Formulation / Manufacturing:	see details
DailyMed Link:	ORUDIS at DailyMed

Drug patent expirations by year for ORUDIS

Recent Clinical Trials for ORUDIS

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Mae Stone Goode Foundation	Phase 2/Phase 3
University of Rochester	Phase 2/Phase 3
Sanford Research	Early Phase 1

See all ORUDIS clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for ORUDIS

M01AE	Propionic acid derivatives
M01A	ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
M01	ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
M	Musculo-skeletal system

M02AA	Antiinflammatory preparations, non-steroids for topical use
M02A	TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
M02	TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
M	Musculo-skeletal system

US Patents and Regulatory Information for ORUDIS

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Wyeth Ayerst	ORUDIS	ketoprofen	CAPSULE;ORAL	018754-001	Jul 31, 1987		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Wyeth Cons	ORUDIS KT	ketoprofen	TABLET;ORAL	020429-001	Oct 6, 1995		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Wyeth Ayerst	ORUDIS	ketoprofen	CAPSULE;ORAL	018754-002	Jan 9, 1986		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Wyeth Ayerst	ORUDIS	ketoprofen	CAPSULE;ORAL	018754-003	Jan 9, 1986		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for ORUDIS

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Wyeth Ayerst	ORUDIS	ketoprofen	CAPSULE;ORAL	018754-003	Jan 9, 1986	⤷ Try a Trial	⤷ Try a Trial
Wyeth Ayerst	ORUDIS	ketoprofen	CAPSULE;ORAL	018754-001	Jul 31, 1987	⤷ Try a Trial	⤷ Try a Trial
Wyeth Ayerst	ORUDIS	ketoprofen	CAPSULE;ORAL	018754-002	Jan 9, 1986	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for ORUDIS

See the table below for patents covering ORUDIS around the world.

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
Czechoslovakia	183613	METHOD FOR PRODUCING DERIVATIVES OF 3-BENZOYLPHENYL ACETIC ACID	⤷ Try a Trial
Yugoslavia	34189		⤷ Try a Trial
Israel	29377	(3-BENZOYLPHENYL)ALKANOIC ACIDS	⤷ Try a Trial
Yugoslavia	82073		⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Summary for ORUDIS

Recent Clinical Trials for ORUDIS

Anatomical Therapeutic Chemical (ATC) Classes for ORUDIS

Make Better Decisions: Try a trial or see plans & pricing